$1.28
0.032.28%
Pre-Market: Sep 16, 7:35 AM EDT
15 minutes delayed
Comments
Loading...
Bright Minds Biosciences (DRUG) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBright Minds Biosciences (NASDAQ:DRUG) Stock Quotes, Forecast and News Summary
Bright Minds Biosciences Stock (NASDAQ: DRUG) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 106.03K |
| Day Range | - - - |
| 52 Wk Range | 0.93 - 2.39 |
| Market Cap | $5.71M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 58 |
| Short Interest | 5.07% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsych...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bright Minds Biosciences (DRUG) stock?
You can purchase shares of Bright Minds Biosciences (NASDAQ:DRUG) through any online brokerage.
Who are Bright Minds Biosciences (DRUG) competitors?
There are no as such competitors for Bright Minds Biosciences.
What is the forecast, or price target, for Bright Minds Biosciences (DRUG) stock?
There is no analysis for Bright Minds Biosciences to provide a consensus price target.
What is the current price for Bright Minds Biosciences (DRUG)?
The stock price for Bright Minds Biosciences (NASDAQ: DRUG) is $1.2785 last updated September 16, 2024 at 7:35 AM EDT.
Does Bright Minds Biosciences (DRUG) pay a dividend?
There are no upcoming dividends for Bright Minds Biosciences.
When is Bright Minds Biosciences (NASDAQ:DRUG) reporting earnings?
Bright Minds Biosciences’s Q4 earnings are confirmed for Thursday, November 14, 2024.
Is Bright Minds Biosciences (DRUG) going to split?
There is no upcoming split for Bright Minds Biosciences.
What sector and industry does Bright Minds Biosciences (DRUG) operate in?
Bright Minds Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.